Literature DB >> 7712648

Dyskeratosis congenita.

R A Drachtman1, B P Alter.   

Abstract

Dyskeratosis congenita is a rare genodermatosis. Malignant deterioration and hematologic complications are well-described features of this syndrome. Correct recognition is essential for proper management. A review of diagnostic considerations and treatment guidelines is presented.

Entities:  

Mesh:

Year:  1995        PMID: 7712648

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  13 in total

1.  A boy with breathlessness, digital clubbing and central cyanosis.

Authors:  Sanne J Gordijn; Paul L P Brand
Journal:  Eur J Pediatr       Date:  2003-12-03       Impact factor: 3.183

Review 2.  Genetic interstitial lung disease.

Authors:  Megan Stuebner Devine; Christine Kim Garcia
Journal:  Clin Chest Med       Date:  2011-12-06       Impact factor: 2.878

Review 3.  The genetics of dyskeratosis congenita.

Authors:  Philip J Mason; Monica Bessler
Journal:  Cancer Genet       Date:  2011-12

Review 4.  Dyskeratosis congenita: a disorder of defective telomere maintenance?

Authors:  Amanda J Walne; Anna Marrone; Inderjeet Dokal
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

Review 5.  The inherited bone marrow failure syndromes.

Authors:  S Deborah Chirnomas; Gary M Kupfer
Journal:  Pediatr Clin North Am       Date:  2013-12       Impact factor: 3.278

6.  Variable expression of Dkc1 mutations in mice.

Authors:  Jun He; Bai-Wei Gu; Jingping Ge; Yuko Mochizuki; Monica Bessler; Philip J Mason
Journal:  Genesis       Date:  2009-06       Impact factor: 2.487

7.  Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita.

Authors:  Tom Vulliamy; Richard Beswick; Michael Kirwan; Anna Marrone; Martin Digweed; Amanda Walne; Inderjeet Dokal
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-03       Impact factor: 11.205

Review 8.  Advances in the understanding of dyskeratosis congenita.

Authors:  Amanda J Walne; Inderjeet Dokal
Journal:  Br J Haematol       Date:  2009-02-04       Impact factor: 6.998

9.  Telomerase dysfunction and dyskeratosis congenita.

Authors:  Amanda J Walne; Inderjeet Dokal
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

Review 10.  Human diseases of telomerase dysfunction: insights into tissue aging.

Authors:  Christine Kim Garcia; Woodring E Wright; Jerry W Shay
Journal:  Nucleic Acids Res       Date:  2007-10-02       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.